Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity

被引:224
作者
McGill, Anne-Thea [1 ,4 ]
Stewart, Joanna M. [4 ]
Lithander, Fiona E. [1 ,2 ,3 ]
Strik, Caroline M. [1 ]
Poppitt, Sally D. [1 ,2 ]
机构
[1] Univ Auckland, Human Nutr Unit, Auckland 1, New Zealand
[2] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand
[3] Univ Auckland, Sch Med Sci, Auckland 1, New Zealand
[4] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand
关键词
D O I
10.1186/1475-2891-7-4
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Low serum 25 hydroxyvitamin D-3 (vitamin D-3) is known to perturb cellular function in many tissues, including the endocrine pancreas, which are involved in obesity and type II diabetes mellitus (TIIDM). Vitamin D-3 insufficiency has been linked to obesity, whether obesity is assessed by body mass index (BMI) or waist circumference (waist). Central obesity, using waist as the surrogate, is associated with the metabolic syndrome (MetSyn), insulin resistance, TIIDM and atherosclerotic cardiovascular disease (CVD). We tested how vitamin D-3 was related to measures of fat mass, MetSyn markers, haemoglobin A(1c) (HbA(1c)) and MetSyn in a cross-sectional sample of 250 overweight and obese adults of different ethnicities. There were modest inverse associations of vitamin D-3 with body weight (weight) (r = -0.21, p = 0.0009), BMI (r = -0.18, p = 0.005), waist (r = -0.14, p = 0.03), [but not body fat % (r = -0.08, p = 0.24)], and HbA(1c) (r = -0.16, p = 0.01). Multivariable regression carried out separately for BMI and waist showed a decrease of 0.74 nmol/L (p = 0.002) in vitamin D-3 per 1 kg/m(2) increase in BMI and a decrease of 0.29 nmol/L (p = 0.01) per 1 cm increase in waist, with each explaining approximately 3% of the variation in vitamin D-3 over and above gender, age, ethnicity and season. The similar relationships of BMI and waist with vitamin D-3 may have been due to associations between BMI and waist, or coincidental, where different mechanisms relating hypovitaminosis D-3 to obesity occur concurrently. Previously reviewed mechanisms include that 1) low vitamin D-3, may impair insulin action, glucose metabolism and various other metabolic processes in adipose and lean tissue 2) fat soluble-vitamin D-3 is sequestered in the large adipose compartment, and low in serum, 3) obese people may be sensitive about their body shape, minimising their skin exposure to view and sunlight (not tested). We showed evidence for the first theory but no evidence to support the second. In the current study, serum vitamin D-3 was inversely related to weight, BMI and markers of TIIDM (large waist, raised HbA(1c)) but not to adipose mass nor to MetSyn per se.
引用
收藏
页数:5
相关论文
共 36 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]   Hypovitaminosis D osteopathy: Is it mediated through PTH, lean mass, or is it a direct effect? [J].
Arabi, Asma ;
Baddoura, Rafic ;
Awada, Hassane ;
Salamoun, Mariana ;
Ayoub, Ghazi ;
El-Hajj Fuleihan, Ghada .
BONE, 2006, 39 (02) :268-275
[4]   Body fat content and 25-hydroxyvitamin D levels in healthy women [J].
Arunabh, S ;
Pollack, S ;
Yeh, J ;
Aloia, JF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) :157-161
[5]   Enhanced VDUP-1 gene expression by PPARγ agonist induces apoptosis in human mlacrophage [J].
Billiet, L. ;
Furman, C. ;
Larigauderie, G. ;
Copin, C. ;
Page, S. ;
Fruchart, J. -C. ;
Brand, K. ;
Rouis, M. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2008, 214 (01) :183-191
[6]  
BOTELLACARRETER.J, 2007, CLIN NUTR
[7]   Inadequate vitamin D status: does it contribute to the disorders comprising syndrome 'X'? [J].
Boucher, BJ .
BRITISH JOURNAL OF NUTRITION, 1998, 79 (04) :315-327
[8]   VITAMIN-D STATUS AND BONE HISTOMORPHOMETRY IN GROSS OBESITY [J].
COMPSTON, JE ;
VEDI, S ;
LEDGER, JE ;
WEBB, A ;
GAZET, JC ;
PILKINGTON, TRE .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1981, 34 (11) :2359-2363
[9]   Concentrations of serum vitamin D and the metabolic syndrome among US adults [J].
Ford, ES ;
Ajani, UA ;
McGuire, LC ;
Liu, S .
DIABETES CARE, 2005, 28 (05) :1228-1230
[10]   Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421